{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:21:36Z","timestamp":1741238496282,"version":"3.38.0"},"reference-count":12,"publisher":"JLE","issue":"3","content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.nephro.2013.11.009","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T01:45:10Z","timestamp":1400291110000},"page":"183-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["La vitamine\u00a0B3\u00a0pour pr\u00e9venir la polykystose r\u00e9nale autosomique dominante"],"prefix":"10.1684","volume":"10","author":[{"given":"Amina","family":"Al Adlouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2013.11.009_bib0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","article-title":"Estimating prevalence in single-gene kidney diseases progressing to renal failure","volume":"58","author":"Levy","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2013.11.009_bib0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.009_bib0015","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.009_bib0020","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.009_bib0025","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1\u00a0inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nephro.2013.11.009_bib0030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMra1100831","article-title":"Epstein lecture: sirtuins, aging, and medicine","volume":"364","author":"Guarente","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2013.11.009_bib0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tibs.2005.07.004","article-title":"Vitamin B3\u00a0and sirtuin function","volume":"30","author":"Denu","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nephro.2013.11.009_bib0040","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/hmg\/10.21.2385","article-title":"Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1\u00a0causes cystogenesis and bone defects","volume":"10","author":"Lu","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nephro.2013.11.009_bib0045","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nephro.2013.11.009_bib0050","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1\u00a0expression is sufficient to cause polycystic kidney disease","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nephro.2013.11.009_bib0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dev.049437","article-title":"Polycystin-dependent fluid flow sensing targets histone deacetylase 5\u00a0to prevent the development of renal cysts","volume":"137","author":"Xia","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.nephro.2013.11.009_bib0060","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.1073\/pnas.0911987106","article-title":"Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models","volume":"106","author":"Cao","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725514000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725514000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2013.11.009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:58:39Z","timestamp":1741186719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725514000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1769725514000108"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2013.11.009","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La vitamine\u00a0B3\u00a0pour pr\u00e9venir la polykystose r\u00e9nale autosomique dominante","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}